Profile | GDS5420 / 231729_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 182.79 | 51 |
GSM1296119 | B_lesional_pre-dose | 15.37 | 12 |
GSM1296076 | C_lesional_pre-dose | 57.79 | 33 |
GSM1296092 | D_lesional_pre-dose | 67.23 | 38 |
GSM1296103 | E_lesional_pre-dose | 137.12 | 47 |
GSM1296078 | F_lesional_pre-dose | 34.52 | 25 |
GSM1296107 | G_lesional_pre-dose | 42.59 | 26 |
GSM1296109 | H_lesional_pre-dose | 64.27 | 33 |
GSM1296080 | I_lesional_pre-dose | 63.83 | 36 |
GSM1296090 | J_lesional_pre-dose | 42.98 | 30 |
GSM1296074 | K_lesional_pre-dose | 39.59 | 29 |
GSM1296111 | L_lesional_pre-dose | 52.88 | 29 |
GSM1296099 | M_lesional_pre-dose | 137.22 | 46 |
GSM1296086 | O_lesional_pre-dose | 51.42 | 33 |
GSM1296117 | P_lesional_pre-dose | 59.77 | 31 |
GSM1296113 | Q_lesional_pre-dose | 33.48 | 20 |
GSM1296096 | R_lesional_pre-dose | 79.26 | 39 |
GSM1296105 | S_lesional_pre-dose | 96.11 | 40 |
GSM1296098 | T_lesional_pre-dose | 192.37 | 51 |
GSM1296101 | U_lesional_pre-dose | 169.62 | 49 |
GSM1296121 | V_lesional_pre-dose | 61.7 | 33 |
GSM1296088 | W_lesional_pre-dose | 52.52 | 33 |
GSM1296082 | X_lesional_pre-dose | 68.23 | 37 |
GSM1296115 | Y_lesional_pre-dose | 88.16 | 38 |
GSM1296084 | Z_lesional_pre-dose | 71.38 | 36 |
GSM1296072 | B_lesional_day8 | 71.63 | 34 |
GSM1296069 | L_lesional_day8 | 52.18 | 28 |
GSM1296071 | P_lesional_day8 | 140.48 | 44 |
GSM1296070 | Y_lesional_day8 | 144.49 | 45 |
GSM1296073 | V_lesional_day8 | 70.89 | 35 |
GSM1296034 | A_lesional_day15 | 465.94 | 66 |
GSM1296041 | G_lesional_day15 | 83.91 | 37 |
GSM1296035 | R_lesional_day15 | 113.74 | 44 |
GSM1296038 | U_lesional_day15 | 163.83 | 49 |
GSM1296047 | B_lesional_day15 | 74 | 34 |
GSM1296039 | E_lesional_day15 | 114.22 | 44 |
GSM1296042 | H_lesional_day15 | 112.84 | 41 |
GSM1296043 | L_lesional_day15 | 90.62 | 37 |
GSM1296037 | M_lesional_day15 | 181.83 | 50 |
GSM1296046 | P_lesional_day15 | 51.54 | 28 |
GSM1296044 | Q_lesional_day15 | 107.87 | 40 |
GSM1296045 | Y_lesional_day15 | 192.32 | 50 |
GSM1296025 | C_lesional_day15 | 63.63 | 35 |
GSM1296033 | D_lesional_day15 | 111.28 | 43 |
GSM1296027 | I_lesional_day15 | 131.43 | 48 |
GSM1296032 | J_lesional_day15 | 75.42 | 37 |
GSM1296024 | K_lesional_day15 | 100.41 | 42 |
GSM1296031 | W_lesional_day15 | 109.96 | 42 |
GSM1296028 | X_lesional_day15 | 116.6 | 44 |
GSM1296029 | Z_lesional_day15 | 82.74 | 39 |
GSM1296026 | F_lesional_day15 | 56.57 | 33 |
GSM1296030 | O_lesional_day15 | 93.51 | 43 |
GSM1296040 | S_lesional_day15 | 111.4 | 42 |
GSM1296036 | T_lesional_day15 | 118.83 | 43 |
GSM1296048 | V_lesional_day15 | 96.69 | 40 |
GSM1296059 | A_lesional_day43 | 136.06 | 47 |
GSM1296066 | G_lesional_day43 | 81.78 | 36 |
GSM1296060 | R_lesional_day43 | 190.23 | 51 |
GSM1296063 | U_lesional_day43 | 162.39 | 49 |
GSM1296064 | E_lesional_day43 | 45.06 | 30 |
GSM1296067 | H_lesional_day43 | 128.67 | 43 |
GSM1296062 | M_lesional_day43 | 126.17 | 45 |
GSM1296068 | Q_lesional_day43 | 116.11 | 40 |
GSM1296050 | C_lesional_day43 | 14.26 | 12 |
GSM1296057 | D_lesional_day43 | 250.97 | 56 |
GSM1296052 | I_lesional_day43 | 156.24 | 50 |
GSM1296054 | J_lesional_day43 | 47.34 | 29 |
GSM1296049 | K_lesional_day43 | 57.06 | 33 |
GSM1296055 | W_lesional_day43 | 213.17 | 52 |
GSM1296053 | X_lesional_day43 | 43.37 | 29 |
GSM1296058 | Z_lesional_day43 | 171.94 | 51 |
GSM1296051 | F_lesional_day43 | 33.32 | 25 |
GSM1296056 | O_lesional_day43 | 62.14 | 36 |
GSM1296065 | S_lesional_day43 | 163.56 | 49 |
GSM1296061 | T_lesional_day43 | 175.38 | 50 |
GSM1296095 | A_non-lesional_pre-dose | 206.46 | 53 |
GSM1296120 | B_non-lesional_pre-dose | 43.76 | 26 |
GSM1296077 | C_non-lesional_pre-dose | 38.44 | 28 |
GSM1296093 | D_non-lesional_pre-dose | 102.5 | 41 |
GSM1296104 | E_non-lesional_pre-dose | 96.79 | 41 |
GSM1296079 | F_non-lesional_pre-dose | 71.03 | 36 |
GSM1296108 | G_non-lesional_pre-dose | 189.4 | 50 |
GSM1296110 | H_non-lesional_pre-dose | 142.47 | 44 |
GSM1296081 | I_non-lesional_pre-dose | 91.89 | 42 |
GSM1296091 | J_non-lesional_pre-dose | 108.06 | 44 |
GSM1296075 | K_non-lesional_pre-dose | 27.91 | 22 |
GSM1296112 | L_non-lesional_pre-dose | 212.36 | 51 |
GSM1296100 | M_non-lesional_pre-dose | 190.04 | 51 |
GSM1296087 | O_non-lesional_pre-dose | 75.37 | 40 |
GSM1296118 | P_non-lesional_pre-dose | 113.21 | 40 |
GSM1296114 | Q_non-lesional_pre-dose | 33.11 | 21 |
GSM1296097 | R_non-lesional_pre-dose | 314.16 | 60 |
GSM1296106 | S_non-lesional_pre-dose | 121.73 | 43 |
GSM1296102 | U_non-lesional_pre-dose | 215.02 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 78.14 | 35 |
GSM1296089 | W_non-lesional_pre-dose | 158.5 | 48 |
GSM1296083 | X_non-lesional_pre-dose | 53.65 | 32 |
GSM1296116 | Y_non-lesional_pre-dose | 115.76 | 40 |
GSM1296085 | Z_non-lesional_pre-dose | 103.88 | 42 |